Genesee Capital Advisors, LLC Atri Cure, Inc. Transaction History

Genesee Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 25, 2022	SELL	$57.43 - $71.39 $1.49 Million - $1.85 Million	-25,911 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$63.4 - $87.14 $104,927 - $144,216	-1,655 Reduced 6.0%	25,911 $1.8 Million
Q3 2021 Oct 14, 2021	BUY	$69.28 - $84.46 $1.91 Million - $2.33 Million	27,566 New	27,566 $1.92 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.63B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.